Scott D. Grosse

Vaccine value profile for cytomegalovirus

Preterm birth lifetime costs in the United States in 2016: An update

Healthcare Costs of Pediatric Autism Spectrum Disorder in the United States, 2003–2015

Ensuring the Life-Span Benefits of Newborn Screening

Data needed to respond appropriately to anemia when it is a public health problem

Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac Deaths

Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted?

Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review

Screening for Congenital Cytomegalovirus After Newborn Hearing Screening: What Comes Next?

Retrospective Assessment of Cost Savings From Prevention

Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation

Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State

Evaluating Harms in the Assessment of Net Benefit: A Framework for Newborn Screening Condition Review

Databases for Congenital Heart Defect Public Health Studies Across the Lifespan

The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs

Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005–2010

Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under‐five mortality

Universal State Newborn Screening Programs Can Reduce Health Disparities

Cost-Effectiveness of Routine Screening for Critical Congenital Heart Disease in US Newborns